Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) agonists to improve ex vivo expansion of tumor infiltrating lymphocytes (TILS)

Use of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) agonists to improve ex vivo expansion of tumor infiltrating lymphocytes (TILS)

US Patent 12048717 · Granted Jul 30, 2024

Estimated economic value: $232,799,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Expression of metabolic modulators in tumor microenvironment to improve tumor th2023
Genetic re-engineering of immune cells to improve metabolic fitness for immunoth2023
Therapies based on control of regulatory T cell stability and function via a neu2017